Literature DB >> 33385209

Feasibility of a Home-Based Palliative Care Intervention for Elderly Multimorbid Survivors of Critical Illness.

Florian B Mayr1, Judith L Plowman2, Sandra Blakowski3, Kimberly Sell-Shemansky4, Joleene M Young5, Sachin Yende6.   

Abstract

BACKGROUND: Elderly patients frequently experience deteriorating health after critical illness, which may threaten their independence and predispose them to unplanned hospital readmissions and premature death.
OBJECTIVES: To evaluate the operational feasibility of a 90-day home-based palliative care intervention in multimorbid elderly Veteran survivors of critical illness.
METHODS: A multidisciplinary home-based palliative care intervention was provided for multimorbid elderly veterans who were discharged home after admission to the intensive care unit for sepsis, pneumonia, heart failure, or exacerbation of chronic obstructive lung disease.
RESULTS: Fifteen patients enrolled in the study, 11 (73%) of whom completed all visits; thus the prespecified goal of >70% completion was met. Median (interquartile range [IQR]) age of the patients was 76 (69-87) years. Participants had a median (IQR) of 8 (7-8) concurrent chronic health conditions, were moderately debilitated at baseline, and were all male. The median (IQR) time to the first study visit was 8 (5-12) days. Patients had a median (IQR) of 8 (5-11) in-home visits and 6 (3-7) telephone encounters during the 90-day study period. Nurses spent a median (IQR) cumulative time of 330 (240-585) minutes on home visits and 30 (10-70) minutes on telephone visits. The median (IQR) time per home provider visit was 90 (75-90) minutes. We estimated the median (IQR) cost per patient to be $2321 ($1901-$3331).
CONCLUSION: A comprehensive home-based palliative care intervention is operationally feasible in elderly multi-morbid survivors of critical illness and may result in improved physical functioning and quality of life and fewer unplanned emergency department visits. ©2021 American Association of Critical-Care Nurses.

Entities:  

Year:  2021        PMID: 33385209      PMCID: PMC8010647          DOI: 10.4037/ajcc2021117

Source DB:  PubMed          Journal:  Am J Crit Care        ISSN: 1062-3264            Impact factor:   2.228


  8 in total

1.  Home discharge following critical illness: A qualitative analysis of family caregiver experience.

Authors:  JiYeon Choi; Jennifer H Lingler; Michael P Donahoe; Mary Beth Happ; Leslie A Hoffman; Judith A Tate
Journal:  Heart Lung       Date:  2018-05-03       Impact factor: 2.210

Review 2.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

3.  Palliative performance scale (PPS): a new tool.

Authors:  F Anderson; G M Downing; J Hill; L Casorso; N Lerch
Journal:  J Palliat Care       Date:  1996       Impact factor: 2.250

Review 4.  Critical Care Follow-up Clinics: A Scoping Review of Interventions and Outcomes.

Authors:  Sue Lasiter; Sylwia K Oles; James Mundell; Susan London; Babar Khan
Journal:  Clin Nurse Spec       Date:  2016 Jul-Aug       Impact factor: 1.067

5.  Longitudinal Changes in ICU Admissions Among Elderly Patients in the United States.

Authors:  Michael W Sjoding; Hallie C Prescott; Hannah Wunsch; Theodore J Iwashyna; Colin R Cooke
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

6.  The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients.

Authors:  E Bruera; N Kuehn; M J Miller; P Selmser; K Macmillan
Journal:  J Palliat Care       Date:  1991       Impact factor: 2.250

7.  Cost analysis of the very elderly admitted to intensive care units.

Authors:  Nicolas Chin-Yee; Gianni D'Egidio; Kednapa Thavorn; Daren Heyland; Kwadwo Kyeremanteng
Journal:  Crit Care       Date:  2017-05-16       Impact factor: 9.097

8.  Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework.

Authors:  Sandra M Eldridge; Gillian A Lancaster; Michael J Campbell; Lehana Thabane; Sally Hopewell; Claire L Coleman; Christine M Bond
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.